Israeli medical analytics startup Clew announced on Tuesday that it received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its ICU solution, which allows healthcare providers to help identify patients at risk of being diagnosed with respiratory failure or hemodynamic instability, two common complications associated with COVID-19.
Israeli startup, CLEW, gets emergency FDA clearance for the company’s remote proactive health monitoring solution for COVID & ICU patients. Further disconnecting medical personnel from potentially contagious patients…
Clinicians and AI researchers from CLEEW Med announced today that the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the firm’s CLEWICU system.
Calcalist and CTech compiled a list of the most forward looking startups in this promising field, which was only strengthened by the outbreak of Covid-19
What we know already is that scientists and researchers are working diligently to find treatments and to develop a vaccine for coronavirus. Meanwhile, artificial intelligence technologies are emerging as key solutions to combating coronavirus, and Israel is well positioned in this field.
Healthcare IT vendors may not have known exactly what they were getting ready for, but they have actually been preparing for this pandemic for years. And a lot of the help that vendors offer is easier to obtain than providers may realize.
As the coronavirus pandemic intensifies, stakeholders race against time to implement technologies that ease the burden on the hospitals. We analyzed 125 startups & emerging companies working on hospital care solutions and showcase Diligent Robotics, Isinnova, Ruxin Medical, CLEW, and Sonovia in this article!
CLEW’s platform provides predictive analytics to detect respiratory deterioration in advance.